Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

microRNAs as biomarkers of ovarian cancer
Huilin Zhang, Bingjian Lü
Expert Review of Anticancer Therapy (2020) Vol. 20, Iss. 5, pp. 373-385
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
Э. А. Брага, М. В. Фридман, Alexey A. Moscovtsev, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8855-8855
Open Access | Times Cited: 188
The Role of miRNA in Ovarian Cancer: an Overview
Lihui Zhao, Xiaolei Liang, Liyan Wang, et al.
Reproductive Sciences (2022) Vol. 29, Iss. 10, pp. 2760-2767
Open Access | Times Cited: 45
Exosomal lncRNA ATB Derived from Ovarian Cancer Cells Promotes Angiogenesis via Regulating miR-204-3p/TGFβR2 Axis
Donglan Yuan, Ting Guo, Dandan Zhu, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 327-337
Open Access | Times Cited: 29
MicroRNAs as Potential Biomarkers in Gynecological Cancers
Joanna Miśkiewicz, Aleksandra Mielczarek‐Palacz, Joanna Gola
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1704-1704
Open Access | Times Cited: 15
The Roles of ceRNAs-Mediated Autophagy in Cancer Chemoresistance and Metastasis
Huilin Zhang, Bingjian Lü
Cancers (2020) Vol. 12, Iss. 10, pp. 2926-2926
Open Access | Times Cited: 37
The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review
Neda Baghban, Mujib Ullah, Iraj Nabipour
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Role of lncRNAHCP5/microRNA-525–5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells
Ling Wang, Miao He, Li Fu, et al.
Experimental Cell Research (2020) Vol. 394, Iss. 1, pp. 112129-112129
Closed Access | Times Cited: 30
Spotlight on New Hallmarks of Drug-Resistance towards Personalized Care for Epithelial Ovarian Cancer
Simona Frezzini, Sara Lonardi
Cells (2024) Vol. 13, Iss. 7, pp. 611-611
Open Access | Times Cited: 2
Oncogenic microRNA-181d binding to OGT contributes to resistance of ovarian cancer cells to cisplatin
Wei Huang, Ling Chen, Kean Zhu, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis
Qingfeng Ye, Jundan Wang, Da Xu, et al.
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 12, pp. 1357-1369
Closed Access | Times Cited: 9
Prognostic Significance of Non-Coding RNAs Related to the Tumorigenic Epithelial-Mesenchymal Transition (EMT) Process Among Ovarian Cancer Patients: A Systematic Review and Meta-Analysis
Alireza Soltani Khaboushan, Seyedeh Nazanin Salimian, Saghar Mehraban, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35202-e35202
Open Access | Times Cited: 1
A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer
Min Zhou, Tao Wu, Yuan Yuan, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Targeting miR-5088-5p attenuates radioresistance by suppressing Slug
Hyun Jeong Seok, Jae Yeon Choi, Joo Mi Yi, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 2, pp. 164-173
Open Access | Times Cited: 4
MiR-193a-5p serves as an inhibitor in ovarian cancer cells through RAB11A
Yazhuo Wang, Na Li, Jing Zhao, et al.
Reproductive Toxicology (2022) Vol. 110, pp. 105-112
Closed Access | Times Cited: 6
Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer
Aleksandra Englisz, Marta Smycz‐Kubańska, Aleksandra Mielczarek‐Palacz
Diagnostics (2023) Vol. 13, Iss. 10, pp. 1714-1714
Open Access | Times Cited: 3
High-throughput sequencing identification of differentially expressed microRNAs in metastatic ovarian cancer with experimental validations
Yang Gu, Shulan Zhang
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Spotlight on New Hallmarks of Drug-Resistance towards Personalized Care for Epithelial Ovarian Cancer
Simona Frezzini, Sara Lonardi
(2024)
Open Access
PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex
Lipeng Qiu, Ruyan Li, Yue Wang, et al.
British Journal of Cancer (2024)
Closed Access
MiR-93-5p inhibits ovarian cancer through SLC7A11-mediated-ferroptosis
Chunxia Li, Zitao Wang, Yanqing Wang, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35457-e35457
Open Access
Circ_0001068 accelerates the development of ovarian cancer by promoting FXYD5 expression through inhibiting mir-149-5p activity
Zhengqian Mou, Lingyan Ge, Saiya Ye, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Long non‑coding RNA regulation of TRAIL in breast cancer: A tangle of non‑coding threads (Review)
Zeeshan Javed, Khushbukhat Khan, Muhammad Iqbal, et al.
Oncology Letters (2020)
Open Access | Times Cited: 4
Identifying Novel Candidate Biomarkers of Early Epithelial Ovarian Cancer
Sarah Sczelecki
(2023)
Open Access
Identification of Differentially Expressed microRNAs in Metastatic Ovarian Cancer
Yang Gu, Shulan Zhang
Research Square (Research Square) (2020)
Open Access
High-Throughput Sequencing Identification of Differentially Expressed microRNAs in Metastatic Ovarian Cancer with Experimental Validations
Yang Gu, Shulan Zhang
Research Square (Research Square) (2020)
Open Access
High-Throughput Sequencing Identification of Differentially Expressed microRNAs in Metastatic Ovarian Cancer with experimental validations
Yang Gu, Shulan Zhang
Research Square (Research Square) (2020)
Open Access
Page 1 - Next Page

Scroll to top